Viewing StudyNCT06237881



Ignite Creation Date: 2024-05-06 @ 8:03 PM
Last Modification Date: 2024-10-26 @ 3:19 PM
Study NCT ID: NCT06237881
Status: RECRUITING
Last Update Posted: 2024-05-02
First Post: 2024-01-25

Brief Title: A Phase 12 Study of KSQ-001EX Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate the SOCS1 Gene in Patients With Select Advanced Solid Tumors
Sponsor: MD Anderson Cancer Center
Organization: MD Anderson Cancer Center

Organization Data

Organization: MD Anderson Cancer Center
Class: OTHER
Study ID: 2023-0571
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: MD Anderson Cancer Center
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
KSQ Therapeutics Inc INDUSTRY